Immunotherapy improves lung cancer outcomes : comparemela.co

Immunotherapy given before and after surgery significantly improved outcomes in patients with operable non-small cell lung cancer.

Related Keywords

United States , American , Elissa Wolfson , John Heymach , University Of Texas , American Association For Cancer Research , Astrazeneca , Science Advisory Board , American Association , Cancer Research , Lung Cancer , Non Small Cell Lung Cancer , Nsclc , Esectable Cancer , Adjuvant , Neoadjuvant , Durvalumab , Platinum Based Chemotherapy , Djuvant Placebo , Tremelimumab , Chemoradiotherapy , Pathologic Complete Response , Event Free Survival , University Of Texas Md Anderson Cancer Center , Racr ,